Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis
NCT ID: NCT02877537
Last Updated: 2016-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
177 participants
INTERVENTIONAL
2008-10-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project could allow a better identification of asthmatic individuals needing a treatment, a reduction of morbidity of asthma, a reduction of unnecessary treatments administered in individuals with respiratory but not asthmatic symptoms, a better comprehension of bronchial hyperreactivity and its role in asthmatic disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Structured Light Plethysmography in Obstructive Airways Disease
NCT03499938
Forced Oscillations Technique During a Metacholine Test in Children
NCT05734261
High Flow Nasal Cannula in Children With Status Asthmaticus
NCT03157102
Status Asthmaticus on the PICU; Intravenous Salbutamol
NCT03493503
Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet
NCT03042065
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asthma child
Salbutamol
bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber
Forced oscillation technique
before and after bronchodilation
Plethysmography
Control adult
Salbutamol
bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber
Forced oscillation technique
before and after bronchodilation
Plethysmography
Control child
Salbutamol
bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber
Forced oscillation technique
before and after bronchodilation
Plethysmography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Salbutamol
bronchodilation obtained with 2 inhalations of salbutamol (100 µg per dose) with inhalation chamber
Forced oscillation technique
before and after bronchodilation
Plethysmography
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Several episodes of paroxysmal wheezes, spontaneous or after exercise, without bronchial-pulmonary infection
* Absence of bronchodilator taking during last 12 hours
* Absence of reported intolerance to adrenergic substances
* Parental authorization and consent of child to participate to the study
Control children group:
\- Parental authorization and consent of child to participate to the study
Control adult group:
\- Consent to participate to the study
Exclusion Criteria
* At least 2 episodes of wheezes during breathing
* Several wheezes, abnormal breathlessness, cough during physical exercise
* Asthma diagnosed by family doctor
* Administration of drugs to treat asthma
* Eczema or food allergy at inclusion
* Episode of cough for longer than 6 weeks, without bronchial infection
* Bronchitis, throat infection, rhino-pharyngitis during last 15 days
* Paleness or cyanosis with loss of consciousness when the child was a baby or during an exercise
3 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François MARCHAL
Role: PRINCIPAL_INVESTIGATOR
CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nancy - Hôpital BRABOIS Enfants - Explorations fonctionnelles pédiatriques
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-002822-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.